ATE426169T1 - Fruher nachweis einer lysosomalen speicher- krankheit - Google Patents

Fruher nachweis einer lysosomalen speicher- krankheit

Info

Publication number
ATE426169T1
ATE426169T1 AT97920460T AT97920460T ATE426169T1 AT E426169 T1 ATE426169 T1 AT E426169T1 AT 97920460 T AT97920460 T AT 97920460T AT 97920460 T AT97920460 T AT 97920460T AT E426169 T1 ATE426169 T1 AT E426169T1
Authority
AT
Austria
Prior art keywords
lysosomal storage
early detection
storage disease
detection
lamp
Prior art date
Application number
AT97920460T
Other languages
German (de)
English (en)
Inventor
Peter Meikle
Douglas Brooks
John Hopwood
Original Assignee
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens & Childrens Hospital filed Critical Womens & Childrens Hospital
Application granted granted Critical
Publication of ATE426169T1 publication Critical patent/ATE426169T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT97920460T 1996-05-17 1997-05-16 Fruher nachweis einer lysosomalen speicher- krankheit ATE426169T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN9917A AUPN991796A0 (en) 1996-05-17 1996-05-17 Early detection of lysosomal storage disorders

Publications (1)

Publication Number Publication Date
ATE426169T1 true ATE426169T1 (de) 2009-04-15

Family

ID=3794228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920460T ATE426169T1 (de) 1996-05-17 1997-05-16 Fruher nachweis einer lysosomalen speicher- krankheit

Country Status (10)

Country Link
US (2) US6759189B1 (enExample)
EP (1) EP1021725B1 (enExample)
JP (3) JP3837711B2 (enExample)
AT (1) ATE426169T1 (enExample)
AU (1) AUPN991796A0 (enExample)
CA (2) CA2253875C (enExample)
DE (1) DE69739317D1 (enExample)
IL (1) IL127033A (enExample)
NZ (1) NZ332641A (enExample)
WO (1) WO1997044668A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002543425A (ja) * 1999-04-30 2002-12-17 ザ ナタン エス. クライン インスティテュート フォー サイキアトリック リサーチ アルツハイマー病の治療のための化合物の同定法
US7090987B1 (en) 1999-04-30 2006-08-15 Nixon Ralph A Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia
NZ543309A (en) 2003-03-31 2008-12-24 Womens & Childrens Hospital Multiplex screening for lysosomal storage disorders (LSDs)
US7615224B2 (en) * 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
ES2301280A1 (es) * 2005-05-16 2008-06-16 Fina Biotech S.L.U. Metodo para diagnosticar la enfermedad de alzheimer.
WO2007136782A2 (en) * 2006-05-19 2007-11-29 Historx, Inc. Kits and methods for evaluating misfolded proteins
EP2209890A4 (en) * 2006-12-13 2011-11-02 Tgr Biosciences Pty Ltd STIMULATION OF PRODUCTION OF EXTRACELLULAR MEDIA WITH FIBROBLAST CELLS AND / OR STIMULATION OF MIGRATION OF FIBROBLAST CELLS IN A BIOLOGICAL SYSTEM
EP2252325A4 (en) * 2008-03-12 2012-07-11 Amicus Therapeutics Inc TREATMENT OF MORBUS POMPE WITH SPECIFIC PHARMACOLOGICAL CHAPTERONES AND TREATMENT MONITORING WITH SURROGATE MARKERS
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
GB201114909D0 (en) * 2011-08-30 2011-10-12 San Raffaele Centro Fond Biomarkers for lysosomal storage disorders
US8293487B1 (en) * 2012-01-06 2012-10-23 Jiandi Zhang Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process
US9983200B2 (en) 2013-03-14 2018-05-29 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
US12020820B1 (en) 2017-03-03 2024-06-25 Cerner Innovation, Inc. Predicting sphingolipidoses (fabry's disease) and decision support
US11335461B1 (en) 2017-03-06 2022-05-17 Cerner Innovation, Inc. Predicting glycogen storage diseases (Pompe disease) and decision support
US11923048B1 (en) 2017-10-03 2024-03-05 Cerner Innovation, Inc. Determining mucopolysaccharidoses and decision support tool

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
AU2990692A (en) 1991-12-06 1993-06-10 Commonwealth Scientific And Industrial Research Organisation Diagnostic method for pompe's disease
CA2147887A1 (en) * 1992-10-30 1994-05-11 James W. Dennis Method for measuring glycosyltransferase activity

Also Published As

Publication number Publication date
CA2253875C (en) 2011-02-22
JP2001519894A (ja) 2001-10-23
JP2006061161A (ja) 2006-03-09
CA2253875A1 (en) 1997-11-27
JP2008289501A (ja) 2008-12-04
US6759189B1 (en) 2004-07-06
IL127033A0 (en) 1999-09-22
JP4260152B2 (ja) 2009-04-30
US20040191847A1 (en) 2004-09-30
WO1997044668A1 (en) 1997-11-27
EP1021725B1 (en) 2009-03-18
EP1021725A1 (en) 2000-07-26
NZ332641A (en) 2000-05-26
CA2731490A1 (en) 1997-11-27
DE69739317D1 (de) 2009-04-30
IL127033A (en) 2000-12-06
JP3837711B2 (ja) 2006-10-25
EP1021725A4 (en) 2002-10-30
AUPN991796A0 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
DE69739317D1 (de) Früher nachweis einer lysosomalen speicher-krankheit
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ES2172750T3 (es) Microcapsulas sensibles al ph.
BR9914044A (pt) ésteres tetrahidropirido
EP0693281A3 (en) Pharmaceutical preparations containing fluoxetine
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
ES2190803T3 (es) Iminas ciclicas como pesticidas.
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
EP1402067A4 (en) HS2STS AS P53 PATH MODIFICATORS AND USE METHOD
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
BR9713866A (pt) Composição farmacéutica
WO2003104410A3 (en) ENZYMES
BG105112A (bg) Средство с антидепресивно действие
ES2158054T3 (es) Extracto proteinico de cucumis melo con actividad antioxidante y procedimiento de preparacion, composicion cosmetica o farmaceutica o composicion alimenticia que contienen dicho extracto.
BRPI0414215A (pt) tienopirazóis
BR0200571A (pt) Produtos de legumes
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
CA2069611A1 (en) Method to Detect Bone and Other Connective Tissue Disorders in Humans and Animals
FR2809000B1 (fr) Utilisation d'ergothioneine et/ou de ses derives comme agent anti-pollution
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
DK0977871T3 (da) Neurotrypsin
PT853476E (pt) Preparacao farmaceutica que contem nimesulide para uso topico
BR0115689A (pt) Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
TR199801398T2 (xx) Ast�m� tedavi edici maddeler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties